who makes the glp 1 drugs Reflections on discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions GLP-1 Agonists: A Comprehensive Overview

Cardiovascular Risk Reduction Benefits of GLP-1 RAs for Your Patients With Obesity, Without T2D high risk for cardiovascular disease

Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation

[1] [3] This is particularly relevant for post-bariatric patients, who may already have altered biliary physiology

Aroor AR, Sowers JR, Jia G, DeMarco VG: Pleiotropic Effects of the Dipeptidylpeptidase-4 Inhibitors on the Cardiovascular System

While GLP-1 medications have become well-known, your body naturally produces this hormoneoffering a safer, more sustainable path to metabolic health

Diazoxide choline extended-release tablet in people with Prader-Willi Syndrome: a double-blind, placebo-controlled trial